| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | Call GILD $70.0 Exp Jun 16, 2017 | 39,200 | 3,102,000 | 0.51% | Call | |
| 52 | ACORDA THERAPEUTICS INC | 148,000 | 3,090,000 | 0.50% | ||
| 53 | ENDO INTL PLC | 150,000 | 3,023,000 | 0.49% | ||
| 54 | FIBROGEN INC | 145,700 | 3,016,000 | 0.49% | ||
| 55 | Aldeyra Therapeutics Inc | 368,500 | 2,893,000 | 0.47% | ||
| 56 | DBV TECHNOLOGIES S A | 79,058 | 2,872,000 | 0.47% | ||
| 57 | KITE PHARMA INCORPORATED | 50,000 | 2,793,000 | 0.45% | ||
| 58 | APPLE INC CALL | 18,500 | 2,759,000 | 0.45% | Call | |
| 59 | SNAP ON INC | 18,130 | 2,755,000 | 0.45% | ||
| 60 | Audentes Therapeutics, Inc. | 150,000 | 2,672,000 | 0.44% | ||
| 61 | FORWARD PHARMA A/S | 121,500 | 2,552,000 | 0.42% | ||
| 62 | ISHARES TR | 20,500 | 2,546,000 | 0.41% | Put | |
| 63 | Syndax Pharmaceuticals Inc | 166,310 | 2,521,000 | 0.41% | ||
| 64 | MEDGENICS INC | 450,000 | 2,507,000 | 0.41% | ||
| 65 | VERSARTIS INC | 200,000 | 2,450,000 | 0.40% | ||
| 66 | Marinus Pharmaceuticals Inc | 1,340,588 | 2,440,000 | 0.40% | ||
| 67 | Catabasis Pharmaceuticals Inc | 387,943 | 2,390,000 | 0.39% | ||
| 68 | DERMIRA INC COM | 70,000 | 2,367,000 | 0.39% | ||
| 69 | VistaGen Therapeutics Inc | 544,100 | 2,263,000 | 0.37% | ||
| 70 | STARBUCKS CORP | 41,600 | 2,252,000 | 0.37% | ||
| 71 | Egalet Corp | 292,500 | 2,226,000 | 0.36% | ||
| 72 | ADVANCE AUTO PARTS INC | 14,569 | 2,173,000 | 0.35% | ||
| 73 | ADVAXIS INC COM NEW | 200,000 | 2,138,000 | 0.35% | ||
| 74 | ARDELYX INC COM | 151,813 | 1,964,000 | 0.32% | ||
| 75 | TRILLIUM THERAPEUTICS INC | 132,300 | 1,955,000 | 0.32% | ||
| 76 | XENON PHARMACEUTICALS INC | 228,029 | 1,847,000 | 0.30% | ||
| 77 | PARATEK PHARMACEUTICALS INC | 140,000 | 1,821,000 | 0.30% | ||
| 78 | SUMMIT THERAPEUTICS PLC | 197,450 | 1,813,000 | 0.30% | ||
| 79 | REPROS THERAPEUTICS INC | 863,807 | 1,805,000 | 0.29% | ||
| 80 | ADURO BIOTECH INC | 140,000 | 1,740,000 | 0.28% | ||
| 81 | Nivalis Therapeutics Inc | 204,700 | 1,664,000 | 0.27% | ||
| 82 | KERYX BIOPHARMACEUTICALS INCORPORATED | 311,600 | 1,655,000 | 0.27% | ||
| 83 | EDGE THERAPEUTICS INC | 150,000 | 1,562,000 | 0.25% | ||
| 84 | IMMUNE DESIGN CORP | 203,000 | 1,539,000 | 0.25% | ||
| 85 | BURLINGTON STORES INC | 18,500 | 1,499,000 | 0.24% | ||
| 86 | Pieris Pharmaceuticals | 810,000 | 1,482,000 | 0.24% | ||
| 87 | SHIRE PLC | 7,500 | 1,454,000 | 0.24% | ||
| 88 | VTV THERAPEUTICS INC | 200,000 | 1,438,000 | 0.23% | ||
| 89 | MYOKARDIA INC | 83,240 | 1,360,000 | 0.22% | ||
| 90 | AC IMMUNE SA | 79,800 | 1,314,000 | 0.21% | ||
| 91 | IMMUNOMEDICS INCORPORATED | 400,000 | 1,300,000 | 0.21% | ||
| 92 | PALATIN TECHNOLOGIES INC COM | 1,906,037 | 1,199,000 | 0.20% | ||
| 93 | PALO ALTO NETWORKS INC | 7,052 | 1,124,000 | 0.18% | ||
| 94 | ARBUTUS BIOPHARMA CORP | 300,000 | 1,032,000 | 0.17% | ||
| 95 | SAPIENS INTL CORP N V SHS NEW | 80,844 | 1,032,000 | 0.17% | ||
| 96 | MIRATI THERAPEUTICS INC COM | 150,000 | 992,000 | 0.16% | ||
| 97 | ONCOBIOLOGICS INC | 200,000 | 850,000 | 0.14% | ||
| 98 | ARROWHEAD PHARMACEUTICALS IN | 100,000 | 735,000 | 0.12% | ||
| 99 | ORMAT TECHNOLOGIES INC | 7,640 | 370,000 | 0.06% | ||
| 100 | ALIMERA SCIENCES INC | 200,715 | 299,000 | 0.05% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001178913-16-006879, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
